| Dr Frank K Takyi, MD | |
|
1540 Lake Lansing Rd, Suite 205, Lansing, MI 48912-3756 | |
| (517) 913-3910 | |
| (517) 913-3911 |
| Full Name | Dr Frank K Takyi |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 44 Years |
| Location | 1540 Lake Lansing Rd, Lansing, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164479069 | NPI | - | NPPES |
| 1020682 | Other | MI | MCLAREN HEALTH ADVANTAGE |
| P00452412 | Other | MI | RAILROAD MEDICARE |
| 1603330445 | Other | MI | BCBS/BCN |
| 0M21440037 | Other | MI | MEDICARE ADVANTAGE |
| 200000000897 | Other | MI | PHP FAMILYCARE |
| 1020682 | Other | MI | MCLAREN HEALTH PLAN-COMMERCIAL |
| 1020682 | Other | MI | MCLAREN HEALTH PLAN-MEDICAID |
| 5599685 | Other | MI | AETNA |
| 200000000897 | Other | MI | PHP |
| 4679638 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 4301060006 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Edward W Sparrow Hospital | Lansing, MI | Hospital |
| Mclaren Greater Lansing | Lansing, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Edward W Sparrow Hospital Association | 6709799166 | 522 |
News Archive
Scientists at The Wistar Institute have found a novel mechanism through which mutant p53 enhances metastasis by controlling tumor metabolism. The research, published online in Genes & Development, also revealed how this process is influenced by a naturally occurring p53 gene variant.
Robots can significantly help in the fight against the coronavirus disease (COVID-19) that is spreading across the globe. As the number of cases tops one million, and the death toll reaching 53,000, scientists race to develop a drug or vaccine for the infectious disease. Now, robots are playing a major role in this fight, improving the health and safety of individuals and patients.
BioMarin Pharmaceutical Inc. announced today that it has completed the Phase 1 clinical study of BMN 195, a small molecule utrophin up-regulator, for the treatment of Duchenne muscular dystrophy (DMD). The Phase 1 clinical trial was a single-center, double-blind, placebo-controlled, single-dose escalation study followed by a multiple-dose escalation study in healthy volunteers.
Neuroscientists have provided clear visual evidence that a region of the human brain known as the ventral striatum kicks in during decision-making to weigh the costs versus the benefits of making a physical effort.
› Verified 4 days ago
| Entity Name | Edward W Sparrow Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831139088 PECOS PAC ID: 6709799166 Enrollment ID: O20040102000790 |
News Archive
Scientists at The Wistar Institute have found a novel mechanism through which mutant p53 enhances metastasis by controlling tumor metabolism. The research, published online in Genes & Development, also revealed how this process is influenced by a naturally occurring p53 gene variant.
Robots can significantly help in the fight against the coronavirus disease (COVID-19) that is spreading across the globe. As the number of cases tops one million, and the death toll reaching 53,000, scientists race to develop a drug or vaccine for the infectious disease. Now, robots are playing a major role in this fight, improving the health and safety of individuals and patients.
BioMarin Pharmaceutical Inc. announced today that it has completed the Phase 1 clinical study of BMN 195, a small molecule utrophin up-regulator, for the treatment of Duchenne muscular dystrophy (DMD). The Phase 1 clinical trial was a single-center, double-blind, placebo-controlled, single-dose escalation study followed by a multiple-dose escalation study in healthy volunteers.
Neuroscientists have provided clear visual evidence that a region of the human brain known as the ventral striatum kicks in during decision-making to weigh the costs versus the benefits of making a physical effort.
› Verified 4 days ago
| Entity Name | Sparrow Carson Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598490542 PECOS PAC ID: 7113836701 Enrollment ID: O20040126000046 |
News Archive
Scientists at The Wistar Institute have found a novel mechanism through which mutant p53 enhances metastasis by controlling tumor metabolism. The research, published online in Genes & Development, also revealed how this process is influenced by a naturally occurring p53 gene variant.
Robots can significantly help in the fight against the coronavirus disease (COVID-19) that is spreading across the globe. As the number of cases tops one million, and the death toll reaching 53,000, scientists race to develop a drug or vaccine for the infectious disease. Now, robots are playing a major role in this fight, improving the health and safety of individuals and patients.
BioMarin Pharmaceutical Inc. announced today that it has completed the Phase 1 clinical study of BMN 195, a small molecule utrophin up-regulator, for the treatment of Duchenne muscular dystrophy (DMD). The Phase 1 clinical trial was a single-center, double-blind, placebo-controlled, single-dose escalation study followed by a multiple-dose escalation study in healthy volunteers.
Neuroscientists have provided clear visual evidence that a region of the human brain known as the ventral striatum kicks in during decision-making to weigh the costs versus the benefits of making a physical effort.
› Verified 4 days ago
| Entity Name | Edward W Sparrow Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366498107 PECOS PAC ID: 6709799166 Enrollment ID: O20040311001138 |
News Archive
Scientists at The Wistar Institute have found a novel mechanism through which mutant p53 enhances metastasis by controlling tumor metabolism. The research, published online in Genes & Development, also revealed how this process is influenced by a naturally occurring p53 gene variant.
Robots can significantly help in the fight against the coronavirus disease (COVID-19) that is spreading across the globe. As the number of cases tops one million, and the death toll reaching 53,000, scientists race to develop a drug or vaccine for the infectious disease. Now, robots are playing a major role in this fight, improving the health and safety of individuals and patients.
BioMarin Pharmaceutical Inc. announced today that it has completed the Phase 1 clinical study of BMN 195, a small molecule utrophin up-regulator, for the treatment of Duchenne muscular dystrophy (DMD). The Phase 1 clinical trial was a single-center, double-blind, placebo-controlled, single-dose escalation study followed by a multiple-dose escalation study in healthy volunteers.
Neuroscientists have provided clear visual evidence that a region of the human brain known as the ventral striatum kicks in during decision-making to weigh the costs versus the benefits of making a physical effort.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Frank K Takyi, MD 1540 Lake Lansing Rd, Suite 205, Lansing, MI 48912-3756 Ph: (517) 913-3910 | Dr Frank K Takyi, MD 1540 Lake Lansing Rd, Suite 205, Lansing, MI 48912-3756 Ph: (517) 913-3910 |
News Archive
Scientists at The Wistar Institute have found a novel mechanism through which mutant p53 enhances metastasis by controlling tumor metabolism. The research, published online in Genes & Development, also revealed how this process is influenced by a naturally occurring p53 gene variant.
Robots can significantly help in the fight against the coronavirus disease (COVID-19) that is spreading across the globe. As the number of cases tops one million, and the death toll reaching 53,000, scientists race to develop a drug or vaccine for the infectious disease. Now, robots are playing a major role in this fight, improving the health and safety of individuals and patients.
BioMarin Pharmaceutical Inc. announced today that it has completed the Phase 1 clinical study of BMN 195, a small molecule utrophin up-regulator, for the treatment of Duchenne muscular dystrophy (DMD). The Phase 1 clinical trial was a single-center, double-blind, placebo-controlled, single-dose escalation study followed by a multiple-dose escalation study in healthy volunteers.
Neuroscientists have provided clear visual evidence that a region of the human brain known as the ventral striatum kicks in during decision-making to weigh the costs versus the benefits of making a physical effort.
› Verified 4 days ago
Dr. Jessica Frost, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1215 E Michigan Ave, Lansing, MI 48912 Phone: 517-364-5610 | |
Laura Tate, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1215 E Michigan Ave, Lansing, MI 48912 Phone: 517-364-2570 | |
Dr. Alane Marie Laws-barker, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1100 W Saginaw St, Suite 630, Lansing, MI 48915 Phone: 517-364-6363 Fax: 517-364-6364 | |
Carla Formoso Pico, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1215 E Michigan Ave, Lansing, MI 48912 Phone: 517-364-1000 | |
Dr. Jeffrey C Stieve, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 206 E Michigan Ave, Lansing, MI 48933 Phone: 517-373-3197 | |
Katelyn Ann Smiles, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1215 E Michigan Ave, Lansing, MI 48912 Phone: 517-364-2577 | |
Mohammad Mohsenian, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1200 E Michigan Ave, Suite 305, Lansing, MI 48912 Phone: 517-484-4900 Fax: 517-484-4508 |